DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹2,967 Cr | ₹2,206 Cr | ₹2,369 Cr | ₹388,111 Cr | ₹2,861 Cr |
What is the latest Operating Profit of DIVIS LABORATORIES ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹2,967 Cr |
| Mar2025 | ₹2,206 Cr |
| Mar2024 | ₹2,369 Cr |
| Mar2023 | ₹388,111 Cr |
| Mar2022 | ₹2,861 Cr |
How is Operating Profit of DIVIS LABORATORIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,967 Cr | 34.50 | |
| Mar2025 | ₹2,206 Cr | -6.88 | |
| Mar2024 | ₹2,369 Cr | -99.39 | |
| Mar2023 | ₹388,111 Cr | 13,465.29 | |
| Mar2022 | ₹2,861 Cr | - | |
Compare Operating Profit of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹213,904.1 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| MANKIND PHARMA | ₹102,006.0 Cr | 2.9% | 3.5% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 8.2% |
19.8% |
17.2% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses